NRx Pharmaceuticals Inc. (NRXP)
NASDAQ: NRXP
· Real-Time Price · USD
3.23
-0.11 (-3.29%)
At close: Jun 18, 2025, 3:59 PM
3.29
1.86%
After-hours: Jun 18, 2025, 07:31 PM EDT
-3.29% (1D)
| Bid | 3.16 |
| Market Cap | 55.84M |
| Revenue (ttm) | 4K |
| Net Income (ttm) | -24.11M |
| EPS (ttm) | -1.96 |
| PE Ratio (ttm) | -1.65 |
| Forward PE | 4.66 |
| Analyst | Buy |
| Ask | 3.36 |
| Volume | 213,426 |
| Avg. Volume (20D) | 251,607 |
| Open | 3.34 |
| Previous Close | 3.34 |
| Day's Range | 3.23 - 3.42 |
| 52-Week Range | 1.10 - 6.01 |
| Beta | 1.55 |
About NRXP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRXP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRXP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+24.56%
NRx Pharmaceuticals shares are trading higher afte...
Unlock content with
Pro Subscription
5 months ago
+30.48%
NRX Pharmaceuticals shares are trading higher after the company announced it will acquire Dura Medical with HOPE Therapeutics. Additionally, the company signed a binding term sheet with HOPE with $27 million to fund further acquisitions and pharmaceutical operations.
1 week ago · https://www.defenseworld.net
Squarepoint Ops LLC Makes New Investment in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Squarepoint Ops LLC purchased a new position in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchang...
1 month ago · seekingalpha.com
NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call TranscriptNRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Matthew Duffy – Chief Business Officer Jonathan Javitt – Founder, Chairman, and C...
